Baseline Patient Characteristics
| Characteristics | No (%)n = 90 |
|---|---|
| Mean age, years (SD) | 65 (9.88) |
| Male Gender | 67 (74) |
| ECOG PS | |
| 0 | 34 (41) |
| 1 | 33 (40) |
| > 2 | 15 (18) |
| IMDC Risk Group | |
| Favorable | 12 (14) |
| Intermediate | 61 (69) |
| Poor | 15 (17) |
| Prior Nephrectomy | 67 (97) |
| No of prior systemic therapies, median, No. (range) | 2 (1, 6) |
| No of prior systemic therapies | |
| 1 | 42 (47) |
| 2 | 24 (27) |
| 3 | 16 (18) |
| 4 | 6 (7) |
| > 5 | 2 (2) |
| Most common prior systemic therapies | |
| Sunitinib | 64 (71) |
| Pazopanib | 30 (33) |
| Axitinib | 35 (39) |
| Sites of metastases at baseline | |
| Brain | 14 (16) |
| Bones | 37 (41) |
| Lungs | 65 (72) |
| Liver | 27 (30) |
| Lymph Nodes | 58 (64) |
| Pleural | 18 (20) |
| Adrenal | 20 (22) |